Quanterix Co. (NASDAQ:QTRX) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 28.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 217,957 shares of the company's stock after acquiring an additional 47,873 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.57% of Quanterix worth $2,825,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Hsbc Holdings PLC raised its holdings in Quanterix by 34.7% in the 2nd quarter. Hsbc Holdings PLC now owns 12,738 shares of the company's stock valued at $164,000 after buying an additional 3,279 shares during the period. Emerald Mutual Fund Advisers Trust raised its holdings in Quanterix by 0.8% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company's stock valued at $7,300,000 after buying an additional 4,406 shares during the period. nVerses Capital LLC purchased a new stake in Quanterix in the 3rd quarter valued at about $60,000. Janney Capital Management LLC raised its holdings in Quanterix by 33.6% in the 3rd quarter. Janney Capital Management LLC now owns 23,553 shares of the company's stock valued at $305,000 after buying an additional 5,930 shares during the period. Finally, American Century Companies Inc. raised its holdings in Quanterix by 14.5% in the 2nd quarter. American Century Companies Inc. now owns 56,145 shares of the company's stock valued at $742,000 after buying an additional 7,118 shares during the period. Institutional investors and hedge funds own 86.48% of the company's stock.

Analysts Set New Price Targets

Separately, TD Cowen boosted their price objective on shares of Quanterix from $13.50 to $16.00 and gave the company a "hold" rating in a report on Wednesday, November 13th.

Quanterix Stock Up 9.6 %

NASDAQ:QTRX traded up $0.85 on Tuesday, reaching $9.72. 990,428 shares of the company's stock were exchanged, compared to its average volume of 1,049,011. Quanterix Co. has a 52-week low of $8.21 and a 52-week high of $29.70. The firm has a market capitalization of $374.45 million, a price-to-earnings ratio of -9.17 and a beta of 1.33. The business has a fifty day moving average of $11.07 and a 200-day moving average of $12.48.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its quarterly earnings data on Monday, December 23rd. The company reported ($0.22) EPS for the quarter. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. As a group, equities analysts anticipate that Quanterix Co. will post -0.94 earnings per share for the current year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.